SOPHiA GENETICS Reports Mid-Year Financials
Company Announcements

SOPHiA GENETICS Reports Mid-Year Financials

SOPHiA GENETICS (SOPH) has released an update.

SOPHiA GENETICS SA has reported its unaudited interim condensed consolidated financial results, indicating a gross profit increase for the three and six months ended June 30, 2024, compared to the same periods in 2023. However, the company is also facing significant research and development as well as general and administrative costs, impacting their overall financial position.

For further insights into SOPH stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskSOPHiA GENETICS Q3 2024 Financial Highlights
TheFlySophia Genetics CFO Ross Muken promoted to president, George Cardoza to succeed
TipRanks Auto-Generated NewsdeskSOPHiA GENETICS Faces Financial Challenges Amid Losses
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App